University Health Network, Toronto: Neoplasms trials
The registry lists 48 Neoplasms studies with University Health Network, Toronto as lead sponsor. 15 are open to participants now and 0 have results posted.
Phase 1 11Phase 2 7Phase 4 1No phase 32(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Positioning in RT - Supine vs. UprightNot yet recruitingNCT07765069
- Hypersight and Ethos In Pediatric RadiotherapyRecruitingNCT07528547Not applicable
- STEP2 vs. Routine Early Palliative Care: Randomized Noninferiority TrialRecruitingNCT07446660Not applicable
- Buccal Fat for Transoral Robotic Lateral Oropharyngectomy Defects to and Postoperative PainNot yet recruitingNCT06965738Phase 2
- Emotion and Symptom-Focused Engagement (EASE) for CaregiversRecruitingNCT06367556Not applicable
- Plan Development for Giving Teclistamab in the Outpatient SettingRecruitingNCT06251076Phase 4
- At-home Breast Oncology Care Delivered With E-health SolutionsRecruitingNCT05989477Not applicable
- Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLRecruitingNCT05963217Phase 1
- The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled TrialRecruitingNCT05023785Not applicable
- Study of Pembrolizumab With Bendamustine in Hodgkin LymphomaRecruitingNCT04510636Phase 2
- Immune Resistance Interrogation StudyRecruitingNCT04243720
- CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)RecruitingNCT04151342
- HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSILNot yet recruitingNCT03947775Phase 2
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- Myeloproliferative Neoplasms (MPNs) Patient RegistryRecruitingNCT02760238
- Psychoeducation for AlloHCT CaregiversCompletedNCT07116018Not applicable
- Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant RecipientsCompletedNCT06704243Not applicable
- Pilot Trial of Virtual and In-person STEP2CompletedNCT06326554Not applicable
- Comprehensive Health Assessment for my Cancer Treatment PlanActive, not recruitingNCT05499975Not applicable
- Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative NeoplasmCompletedNCT04926194Phase 2
- Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT04599309
- The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Pilot StudyCompletedNCT04598646Not applicable
- Screening of Cancer Patients to Assess Impact of COVID-19TerminatedNCT04373005
- Cell-free DNA in Hereditary And High-Risk Malignancies 1Active, not recruitingNCT04261972
- Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)Active, not recruitingNCT04135794
- The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT DiseaseActive, not recruitingNCT04122469Not applicable
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer SurvivorsActive, not recruitingNCT03878407
- Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic TherapyActive, not recruitingNCT03712566
- 18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot StudyCompletedNCT03352037Not applicable
- Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDSCompletedNCT03187288Phase 1
- Prospective Comprehensive Molecular Profiling In Neuroendocrine TumorsCompletedNCT02586844
- Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian CancerActive, not recruitingNCT02494791Not applicable
- A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of GenesCompletedNCT02069730Not applicable
- Healthy Bones StudyCompletedNCT01973673Not applicable
- A Study of CFI-400945 Fumarate in Patients With Advanced CancerCompletedNCT01954316Phase 1
- Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative NeoplasmsCompletedNCT01816256Not applicable
- Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in BloodCompletedNCT01543841
- A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic CancerCompletedNCT01542177
- Femoral Bone MetastasesActive, not recruitingNCT01428895Not applicable
- Randomized Controlled Trial of Early Palliative Care for Patients With Advanced CancerActive, not recruitingNCT01248624Not applicable
- Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid TumoursCompletedNCT01163903Phase 1
- Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic MalignancyCompletedNCT00990587Phase 1
- Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
- Combidex USPIO - Ultra-small Superparamagnetic Iron OxideCompletedNCT00188695Phase 1/2
- Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)CompletedNCT00188578Phase 1/2
- Stereotactic Radiotherapy (SRT) Liver (COLD 1)CompletedNCT00152906Phase 1/2
- Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00126620Phase 1
- Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00121277Phase 1